Two doses of the Pfizer vaccine are 93% effective at preventing COVID-19 hospitalization among children aged 12 to 18, according to a study at 19 pediatric hospitals released today by the Centers for Disease Control and Prevention. The study examined prior vaccination status among 464 patients hospitalized with and without COVID-19 between June and September, when the delta variant was predominant, and found nearly all (97%) of the patients hospitalized with COVID-19 were unvaccinated. The authors said the findings “reinforce the importance of vaccination to protect U.S. youths against severe COVID-19.” The Pfizer vaccine is currently the only COVID-19 vaccine authorized for this age group. 

Related News Articles

News
The U.S. District Court for the Eastern District of Missouri today granted a preliminary injunction preventing the Centers for Medicare & Medicaid Services…
Headline
A two-dose series of the Pfizer-BioNTech COVID-19 vaccine was 100% effective against COVID-19 in 12-15 year olds more than four months after the second dose in…
Headline
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., Friday expanded eligibility for COVID-19 booster shots to include all adults…
Headline
The Food and Drug Administration today authorized a single booster dose of the Pfizer or Moderna COVID-19 vaccine for all individuals aged 18 or older at…
Headline
The federal government will purchase 10 million treatment courses of the COVID-19 oral antiviral Paxlovid from Pfizer if the Food and Drug Administration…
Headline
The Occupational Safety and Health Administration has suspended activities related to implementation and enforcement of its Emergency Temporary Standard on…